Vanda Pharmaceuticals Inc. VNDA
$5.22
+3.78%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-08-05 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 8-K | 8-K | 2026-06-05 | View → |
| 4 | 4 | 2026-05-20 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| 8-K | 8-K | 2026-05-06 | View → |
| 4 | 4 | 2026-04-24 | View → |
| DEF 14A | DEF 14A | 2026-04-23 | View → |
| 8-K | 8-K | 2026-04-22 | View → |
| 8-K | 8-K | 2026-04-02 | View → |
| 8-K | 8-K | 2026-03-10 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-02-24 | View → |
| 8-K | 8-K | 2026-02-23 | View → |
| 4 | 4 | 2026-02-19 | View → |
| 4 | 4 | 2026-02-19 | View → |
| 4 | 4 | 2026-02-19 | View → |
| 4 | 4 | 2026-02-19 | View → |
| 4 | 4 | 2026-02-19 | View → |
| 8-K | 8-K | 2026-02-19 | View → |
| S-3 | S-3 | 2026-02-12 | View → |
| 10-K | 10-K | 2026-02-12 | View → |
| 8-K | 8-K | 2026-02-11 | View → |
| 8-K | 8-K | 2026-01-08 | View → |
| 8-K | 8-K | 2025-12-31 | View → |
| 8-K | 8-K | 2025-12-04 | View → |
| 8-K | 8-K | 2025-11-28 | View → |
| 10-Q | 10-Q | 2025-10-30 | View → |
| 8-K | 8-K | 2025-10-29 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $5.22
- Market Cap
- $313.80 million
- 52-Week Range
- $4.14 – $9.94
- Average Volume
- 977K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.